A phase 2 trial of surgery with perioperative INGN 201 (Ad5CMV-p53) gene therapy followed by chemoradiotherapy for advanced, resectable squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx: Report of the southwest oncology group
George H. Yoo, James Moon, Michael LeBlanc, Fulvio Lonardo, Susan Urba, Harold Kim, Ehab Hanna, Terry Tsue, Joseph Valentino, John Ensley, Gregory Wolf
Research output: Contribution to journal › Article › peer-review
61Scopus
citations
Fingerprint
Dive into the research topics of 'A phase 2 trial of surgery with perioperative INGN 201 (Ad5CMV-p53) gene therapy followed by chemoradiotherapy for advanced, resectable squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx: Report of the southwest oncology group'. Together they form a unique fingerprint.